ANA-5 analog (Alzhyme)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameANA-5 analog (Alzhyme)
Drug Alias NameN/A
ClassificationRadiation-emitting productsSmall molecules
Mechanisms of ActionSPECT contrast agentPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuroScientific Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuroScientific Biopharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A